Literature DB >> 34166230

Inflammatory cytokines TNF-α and IL-17 enhance the efficacy of cystic fibrosis transmembrane conductance regulator modulators.

Tayyab Rehman1, Philip H Karp1,2, Ping Tan1, Brian J Goodell1, Alejandro A Pezzulo1, Andrew L Thurman1, Ian M Thornell1, Samantha L Durfey3, Michael E Duffey4, David A Stoltz1,5, Edward F McKone6, Pradeep K Singh3, Michael J Welsh1,2,5.   

Abstract

Without cystic fibrosis transmembrane conductance regulator-mediated (CFTR-mediated) HCO3- secretion, airway epithelia of newborns with cystic fibrosis (CF) produce an abnormally acidic airway surface liquid (ASL), and the decreased pH impairs respiratory host defenses. However, within a few months of birth, ASL pH increases to match that in non-CF airways. Although the physiological basis for the increase is unknown, this time course matches the development of inflammation in CF airways. To learn whether inflammation alters CF ASL pH, we treated CF epithelia with TNF-α and IL-17 (TNF-α+IL-17), 2 inflammatory cytokines that are elevated in CF airways. TNF-α+IL-17 markedly increased ASL pH by upregulating pendrin, an apical Cl-/HCO3- exchanger. Moreover, when CF epithelia were exposed to TNF-α+IL-17, clinically approved CFTR modulators further alkalinized ASL pH. As predicted by these results, in vivo data revealed a positive correlation between airway inflammation and CFTR modulator-induced improvement in lung function. These findings suggest that inflammation is a key regulator of HCO3- secretion in CF airways. Thus, they explain earlier observations that ASL pH increases after birth and indicate that, for similar levels of inflammation, the pH of CF ASL is abnormally acidic. These results also suggest that a non-cell-autonomous mechanism, airway inflammation, is an important determinant of the response to CFTR modulators.

Entities:  

Keywords:  Epithelial transport of ions and water; Genetic diseases; Ion channels; Pulmonology

Mesh:

Substances:

Year:  2021        PMID: 34166230      PMCID: PMC8363270          DOI: 10.1172/JCI150398

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   19.456


  69 in total

1.  Influence of external pH on ciliary beat frequency in human bronchi and bronchioles.

Authors:  C Clary-Meinesz; J Mouroux; J Cosson; P Huitorel; B Blaive
Journal:  Eur Respir J       Date:  1998-02       Impact factor: 16.671

2.  Bestrophin-2 mediates bicarbonate transport by goblet cells in mouse colon.

Authors:  Kuai Yu; Rafael Lujan; Alan Marmorstein; Sherif Gabriel; H Criss Hartzell
Journal:  J Clin Invest       Date:  2010-04-19       Impact factor: 14.808

3.  Interleukin-17A induces bicarbonate secretion in normal human bronchial epithelial cells.

Authors:  James L Kreindler; Carol A Bertrand; Robert J Lee; Thomas Karasic; Shean Aujla; Joseph M Pilewski; Raymond A Frizzell; Jay K Kolls
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-12-12       Impact factor: 5.464

4.  The Slc26a4 transporter functions as an electroneutral Cl-/I-/HCO3- exchanger: role of Slc26a4 and Slc26a6 in I- and HCO3- secretion and in regulation of CFTR in the parotid duct.

Authors:  Nikolay Shcheynikov; Dongki Yang; Youxue Wang; Weizong Zeng; Lawrence P Karniski; Insuk So; Susan M Wall; Shmuel Muallem
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

5.  Dynamic modulation of ANO1/TMEM16A HCO3(-) permeability by Ca2+/calmodulin.

Authors:  Jinsei Jung; Joo Hyun Nam; Hyun Woo Park; Uhtaek Oh; Joo-Heon Yoon; Min Goo Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

Review 6.  Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis.

Authors:  Paul M Quinton
Journal:  Lancet       Date:  2008-08-02       Impact factor: 79.321

7.  Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expression.

Authors:  Guido Veit; Radu G Avramescu; Doranda Perdomo; Puay-Wah Phuan; Miklos Bagdany; Pirjo M Apaja; Florence Borot; Daniel Szollosi; Yu-Sheng Wu; Walter E Finkbeiner; Tamas Hegedus; Alan S Verkman; Gergely L Lukacs
Journal:  Sci Transl Med       Date:  2014-07-23       Impact factor: 17.956

8.  TNF-alpha mediates recruitment of neutrophils and eosinophils during airway inflammation.

Authors:  N W Lukacs; R M Strieter; S W Chensue; M Widmer; S L Kunkel
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

9.  VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.

Authors:  Dominic Keating; Gautham Marigowda; Lucy Burr; Cori Daines; Marcus A Mall; Edward F McKone; Bonnie W Ramsey; Steven M Rowe; Laura A Sass; Elizabeth Tullis; Charlotte M McKee; Samuel M Moskowitz; Sarah Robertson; Jessica Savage; Christopher Simard; Fredrick Van Goor; David Waltz; Fengjuan Xuan; Tim Young; Jennifer L Taylor-Cousar
Journal:  N Engl J Med       Date:  2018-10-18       Impact factor: 91.245

10.  Airway surface liquid pH is not acidic in children with cystic fibrosis.

Authors:  André Schultz; Ramaa Puvvadi; Sergey M Borisov; Nicole C Shaw; Ingo Klimant; Luke J Berry; Samuel T Montgomery; Thien Nguyen; Silvia M Kreda; Anthony Kicic; Peter B Noble; Brian Button; Stephen M Stick
Journal:  Nat Commun       Date:  2017-11-10       Impact factor: 14.919

View more
  6 in total

1.  Ivacaftor Alters Macrophage and Lymphocyte Infiltration in the Lungs Following Lipopolysaccharide Exposure.

Authors:  Kiera H Harwood; Rachel M McQuade; Andrew Jarnicki; Elena K Schneider-Futschik
Journal:  ACS Pharmacol Transl Sci       Date:  2022-06-10

Review 2.  Bicarbonate Transport in Cystic Fibrosis and Pancreatitis.

Authors:  Dora Angyal; Marcel J C Bijvelds; Marco J Bruno; Maikel P Peppelenbosch; Hugo R de Jonge
Journal:  Cells       Date:  2021-12-24       Impact factor: 6.600

Review 3.  Impact of Airway Inflammation on the Efficacy of CFTR Modulators.

Authors:  Carla M P Ribeiro; Martina Gentzsch
Journal:  Cells       Date:  2021-11-22       Impact factor: 6.600

4.  Losartan ameliorates TGF-β1-induced CFTR dysfunction and improves correction by cystic fibrosis modulator therapies.

Authors:  Michael D Kim; Charles D Bengtson; Makoto Yoshida; Asef J Niloy; John S Dennis; Nathalie Baumlin; Matthias Salathe
Journal:  J Clin Invest       Date:  2022-06-01       Impact factor: 19.456

Review 5.  IL-17 Cytokines and Chronic Lung Diseases.

Authors:  Felix Ritzmann; Lars Peter Lunding; Robert Bals; Michael Wegmann; Christoph Beisswenger
Journal:  Cells       Date:  2022-07-06       Impact factor: 7.666

6.  The CFTR Amplifier Nesolicaftor Rescues TGF-β1 Inhibition of Modulator-Corrected F508del CFTR Function.

Authors:  Charles Bengtson; Neerupma Silswal; Nathalie Baumlin; Makoto Yoshida; John Dennis; Sireesha Yerrathota; Michael Kim; Matthias Salathe
Journal:  Int J Mol Sci       Date:  2022-09-19       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.